Other Species / Isoforms
  eEF1B (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K7-ac
_MGFGDLksPAGLQV
0 3
eEF1B (human) _MGFGDLksPAGLQV K7-ac
eEF1B (mouse) _MGFGDLKTPAGLQV K7
eEF1B (rat) _MGFGDLkTPAGLQV K7-ac
eEF1B (rabbit) _MGFGDLKSPAGLQV K7
K7-ub
_MGFGDLksPAGLQV
0 4
eEF1B (human) _MGFGDLksPAGLQV K7-ub
eEF1B (mouse) _MGFGDLkTPAGLQV K7-ub
eEF1B (rat) _MGFGDLKTPAGLQV K7
eEF1B (rabbit) _MGFGDLKSPAGLQV K7
K7-m1
_MGFGDLksPAGLQV
0 1
eEF1B (human) _MGFGDLksPAGLQV K7-m1
eEF1B (mouse) _MGFGDLKTPAGLQV K7
eEF1B (rat) _MGFGDLKTPAGLQV K7
eEF1B (rabbit) _MGFGDLKSPAGLQV K7
K7-sc
_MGFGDLksPAGLQV
0 1
eEF1B (human) _MGFGDLksPAGLQV K7-sc
eEF1B (mouse) _MGFGDLkTPAGLQV K7-sc
eEF1B (rat) _MGFGDLKTPAGLQV K7
eEF1B (rabbit) _MGFGDLKSPAGLQV K7
S8-p
MGFGDLksPAGLQVL
0 16
eEF1B (human) MGFGDLksPAGLQVL S8-p
eEF1B (mouse) MGFGDLkTPAGLQVL T8
eEF1B (rat) MGFGDLkTPAGLQVL T8
eEF1B (rabbit) MGFGDLKSPAGLQVL S8
Y18-p
GLQVLNDyLADKSYI
0 1
eEF1B (human) GLQVLNDyLADKSYI Y18-p
eEF1B (mouse) GLQVLNDYLADKSYI Y18
eEF1B (rat) GLQVLNDYLADKSYI Y18
eEF1B (rabbit) GLQVLNDYLADKSYI Y18
S42-p
VAVFEAVssPPPADL
0 1
eEF1B (human) VAVFEAVssPPPADL S42-p
eEF1B (mouse) VAVFEAVSGPPPADL S42
eEF1B (rat) VAVFEAISGPPPADL S42
eEF1B (rabbit) VAVFEAVSGPPPADL S42
S43-p
AVFEAVssPPPADLC
0 2
eEF1B (human) AVFEAVssPPPADLC S43-p
eEF1B (mouse) AVFEAVSGPPPADLC G43
eEF1B (rat) AVFEAISGPPPADLC G43
eEF1B (rabbit) AVFEAVSGPPPADLC G43
Y56-p
LCHALRWyNHIkSYE
0 1
eEF1B (human) LCHALRWyNHIkSYE Y56-p
eEF1B (mouse) LCHALRWYNHIkSYE Y56
eEF1B (rat) LCHALRWYNHIKSYE Y56
eEF1B (rabbit) LCHALRWYNHIKSYE Y56
K60-ac
LRWyNHIkSYEKEKA
0 1
eEF1B (human) LRWyNHIkSYEKEKA K60-ac
eEF1B (mouse) LRWYNHIKSYEKEKA K60
eEF1B (rat) LRWYNHIKSYEKEKA K60
eEF1B (rabbit) LRWYNHIKSYEKEKA K60
K60-ub
LRWyNHIkSYEKEKA
0 3
eEF1B (human) LRWyNHIkSYEKEKA K60-ub
eEF1B (mouse) LRWYNHIkSYEKEKA K60-ub
eEF1B (rat) LRWYNHIKSYEKEKA K60
eEF1B (rabbit) LRWYNHIKSYEKEKA K60
K60-sc
LRWyNHIkSYEKEKA
0 1
eEF1B (human) LRWyNHIkSYEKEKA K60-sc
eEF1B (mouse) LRWYNHIKSYEKEKA K60
eEF1B (rat) LRWYNHIKSYEKEKA K60
eEF1B (rabbit) LRWYNHIKSYEKEKA K60
K78
GVKKALGKyGPADVE
0 2
eEF1B (human) GVKKALGKyGPADVE K78
eEF1B (mouse) GVKKSLGkyGPssVE K78-ac
eEF1B (rat) GVKKSLGkYGPVSVA K78-ac
eEF1B (rabbit) GIKKALGTYGPADVE T78
K78-ub
GVKKALGkyGPADVE
0 5
eEF1B (human) GVKKALGkyGPADVE K78-ub
eEF1B (mouse) GVKKSLGkyGPssVE K78-ub
eEF1B (rat) GVKKSLGKYGPVSVA K78
eEF1B (rabbit) GIKKALGTYGPADVE T78
Y79-p
VKKALGkyGPADVED
0 7
eEF1B (human) VKKALGkyGPADVED Y79-p
eEF1B (mouse) VKKSLGkyGPssVED Y79-p
eEF1B (rat) VKKSLGkYGPVSVAD Y79
eEF1B (rabbit) IKKALGTYGPADVED Y79
A82
ALGkyGPADVEDttG
0 2
eEF1B (human) ALGkyGPADVEDttG A82
eEF1B (mouse) SLGkyGPssVEDttG S82-p
eEF1B (rat) SLGkYGPVSVADTtG V82
eEF1B (rabbit) ALGTYGPADVEDTTG A82
D83
LGkyGPADVEDttGs
0 9
eEF1B (human) LGkyGPADVEDttGs D83
eEF1B (mouse) LGkyGPssVEDttGs S83-p
eEF1B (rat) LGkYGPVSVADTtGs S83
eEF1B (rabbit) LGTYGPADVEDTTGS D83
T87-p
GPADVEDttGsGAtD
Upstream
0 6
Treatment
  • CXCL12
eEF1B (human) GPADVEDttGsGAtD T87-p
eEF1B (mouse) GPssVEDttGsGAAD T87-p
eEF1B (rat) GPVSVADTtGsGAAD T87
eEF1B (rabbit) GPADVEDTTGSGATD T87
T88-p
PADVEDttGsGAtDs
0 9
eEF1B (human) PADVEDttGsGAtDs T88-p
eEF1B (mouse) PssVEDttGsGAADA T88-p
eEF1B (rat) PVSVADTtGsGAADA T88-p
eEF1B (rabbit) PADVEDTTGSGATDS T88
S90-p
DVEDttGsGAtDsKD
0 29
eEF1B (human) DVEDttGsGAtDsKD S90-p
eEF1B (mouse) sVEDttGsGAADAKD S90-p
eEF1B (rat) SVADTtGsGAADAKD S90-p
eEF1B (rabbit) DVEDTTGSGATDSKD S90
T93-p
DttGsGAtDsKDDDD
0 11
eEF1B (human) DttGsGAtDsKDDDD T93-p
eEF1B (mouse) DttGsGAADAKDDDD A93
eEF1B (rat) DTtGsGAADAKDDDD A93
eEF1B (rabbit) DTTGSGATDSKDDDD T93
S95-p
tGsGAtDsKDDDDId
Upstream
0 71
Treatment
  • nocodazole
  • Torin1
eEF1B (human) tGsGAtDsKDDDDId S95-p
eEF1B (mouse) tGsGAADAKDDDDID A95
eEF1B (rat) tGsGAADAKDDDDID A95
eEF1B (rabbit) TGSGATDSKDDDDID S95
D102-ca
sKDDDDIdLFGsDDE
0 1
eEF1B (human) sKDDDDIdLFGsDDE D102-ca
eEF1B (mouse) AKDDDDIDLFGsDDE D102
eEF1B (rat) AKDDDDIDLFGsDDE D102
eEF1B (rabbit) SKDDDDIDLFGsDDE D102
S106-p
DDIdLFGsDDEEEsE
Upstream
2 523
Treatment
  • antibody
  • Torin1
eEF1B (human) DDIdLFGsDDEEEsE S106-p
eEF1B (mouse) DDIDLFGsDDEEEsE S106-p
eEF1B (rat) DDIDLFGsDDEEEsE S106-p
eEF1B (rabbit) DDIDLFGsDDEEEsE S106-p
S112-p
GsDDEEEsEEAKRLR
1 18
eEF1B (human) GsDDEEEsEEAKRLR S112-p
eEF1B (mouse) GsDDEEEsEEAKKLR S112-p
eEF1B (rat) GsDDEEEsEDAKRLR S112-p
eEF1B (rabbit) GsDDEEEsEEAKRLR S112-p
Y126-p
REERLAQyEskKAkK
Upstream
0 159
Treatment
  • ephrin_B2
eEF1B (human) REERLAQyEskKAkK Y126-p
eEF1B (mouse) REERLAQyEskKAKK Y126-p
eEF1B (rat) REERLAQYESKKAKK Y126
eEF1B (rabbit) REERLAQYESKKAKK Y126
S128-p
ERLAQyEskKAkKPA
0 8
eEF1B (human) ERLAQyEskKAkKPA S128-p
eEF1B (mouse) ERLAQyEskKAKKPA S128-p
eEF1B (rat) ERLAQYESKKAKKPA S128
eEF1B (rabbit) ERLAQYESKKAKKPA S128
K129-ac
RLAQyEskKAkKPAL
0 9
eEF1B (human) RLAQyEskKAkKPAL K129-ac
eEF1B (mouse) RLAQyEskKAKKPAV K129-ac
eEF1B (rat) RLAQYESKKAKKPAV K129
eEF1B (rabbit) RLAQYESKKAKKPAL K129
K129-ub
RLAQyEskKAkKPAL
0 1
eEF1B (human) RLAQyEskKAkKPAL K129-ub
eEF1B (mouse) RLAQyEsKKAKKPAV K129
eEF1B (rat) RLAQYESKKAKKPAV K129
eEF1B (rabbit) RLAQYESKKAKKPAL K129
K129
RLAQyEsKKAkKPAL
0 1
eEF1B (human) RLAQyEsKKAkKPAL K129
eEF1B (mouse) RLAQyEskKAKKPAV K129-sc
eEF1B (rat) RLAQYESKKAKKPAV K129
eEF1B (rabbit) RLAQYESKKAKKPAL K129
K132-ub
QyEskKAkKPALVAK
0 17
eEF1B (human) QyEskKAkKPALVAK K132-ub
eEF1B (mouse) QyEskKAKKPAVVAK K132
eEF1B (rat) QYESKKAKKPAVVAK K132
eEF1B (rabbit) QYESKKAKKPALVAK K132
S140
KPALVAKSsILLDVk
0 1
eEF1B (human) KPALVAKSsILLDVk S140
eEF1B (mouse) KPAVVAKSSILLDVk S140
eEF1B (rat) KPAVVAKssILLDVK S140-p
eEF1B (rabbit) KPALVAKSSILLDVK S140
S141-p
PALVAKSsILLDVkP
0 6
eEF1B (human) PALVAKSsILLDVkP S141-p
eEF1B (mouse) PAVVAKSSILLDVkP S141
eEF1B (rat) PAVVAKssILLDVKP S141-p
eEF1B (rabbit) PALVAKSSILLDVKP S141
K147-ac
SsILLDVkPWDDETD
0 2
eEF1B (human) SsILLDVkPWDDETD K147-ac
eEF1B (mouse) SSILLDVkPWDDETD K147-ac
eEF1B (rat) ssILLDVKPWDDETD K147
eEF1B (rabbit) SSILLDVKPWDDETD K147
K147-ub
SsILLDVkPWDDETD
0 3
eEF1B (human) SsILLDVkPWDDETD K147-ub
eEF1B (mouse) SSILLDVkPWDDETD K147-ub
eEF1B (rat) ssILLDVKPWDDETD K147
eEF1B (rabbit) SSILLDVKPWDDETD K147
S164-p
KLEECVRsIQADGLV
0 1
eEF1B (human) KLEECVRsIQADGLV S164-p
eEF1B (mouse) KLEECVRSIQADGLV S164
eEF1B (rat) KLEECVRSIQADGLV S164
eEF1B (rabbit) KLEECVRSIQADGLV S164
S174-p
ADGLVWGsSkLVPVG
Upstream
0 4
Treatment
  • ischemia
eEF1B (human) ADGLVWGsSkLVPVG S174-p
eEF1B (mouse) ADGLVWGsSkLVPVG S174-p
eEF1B (rat) ADGLVWGSSKLVPVG S174
eEF1B (rabbit) ADGLVWGSSKLVPVG S174
K176-ac
GLVWGsSkLVPVGyG
0 2
eEF1B (human) GLVWGsSkLVPVGyG K176-ac
eEF1B (mouse) GLVWGsSKLVPVGyG K176
eEF1B (rat) GLVWGSSKLVPVGYG K176
eEF1B (rabbit) GLVWGSSKLVPVGYG K176
K176-ub
GLVWGsSkLVPVGyG
0 21
eEF1B (human) GLVWGsSkLVPVGyG K176-ub
eEF1B (mouse) GLVWGsSkLVPVGyG K176-ub
eEF1B (rat) GLVWGSSKLVPVGYG K176
eEF1B (rabbit) GLVWGSSKLVPVGYG K176
Y182-p
SkLVPVGyGIkKLQI
0 16
eEF1B (human) SkLVPVGyGIkKLQI Y182-p
eEF1B (mouse) SkLVPVGyGIkKLQI Y182-p
eEF1B (rat) SKLVPVGYGIKKLQI Y182
eEF1B (rabbit) SKLVPVGYGIKKLQI Y182
K185-ac
VPVGyGIkKLQIQCV
0 12
eEF1B (human) VPVGyGIkKLQIQCV K185-ac
eEF1B (mouse) VPVGyGIkKLQIQCV K185-ac
eEF1B (rat) VPVGYGIKKLQIQCV K185
eEF1B (rabbit) VPVGYGIKKLQIQCV K185
K185-ub
VPVGyGIkKLQIQCV
0 2
eEF1B (human) VPVGyGIkKLQIQCV K185-ub
eEF1B (mouse) VPVGyGIkKLQIQCV K185-ub
eEF1B (rat) VPVGYGIKKLQIQCV K185
eEF1B (rabbit) VPVGYGIKKLQIQCV K185
K185-sc
VPVGyGIkKLQIQCV
0 1
eEF1B (human) VPVGyGIkKLQIQCV K185-sc
eEF1B (mouse) VPVGyGIkKLQIQCV K185-sc
eEF1B (rat) VPVGYGIKKLQIQCV K185
eEF1B (rabbit) VPVGYGIKKLQIQCV K185
Y213-p
QITAFEDyVQSMDVA
0 42
eEF1B (human) QITAFEDyVQSMDVA Y213-p
eEF1B (mouse) QITAFEDYVQSMDVA Y213
eEF1B (rat) QITAFEDYVQSMDVA Y213
eEF1B (rabbit) QITAFEDYVQSMDVA Y213